TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment

NCT04391608 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency
Tenofovir

Interventions

DRUG: Switching to Tenofovir Alafenamide

Sponsor

Mahidol University